4.5 Review

Tiny Drosophila makes giant strides in cancer research

期刊

CANCER SCIENCE
卷 112, 期 2, 页码 505-514

出版社

WILEY
DOI: 10.1111/cas.14747

关键词

anti‐ cancer drug; cancer; Drosophila; genetics; whole‐ body platform

类别

资金

  1. Joint Usage/Research Center for Genetic Medicine, Hokkaido University
  2. Photo-excitonix Project in Hokkaido University
  3. MEXT/JSPS KAKENHI [19H05412, 19K22478, 20H03524, 20K07558]
  4. AMED [JP20ck0106548, JP20cm0106273]
  5. AMED (Translational Research program)
  6. AMED (Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT))
  7. MSD Life Science Foundation
  8. SGH Foundation
  9. Foundation for Promotion of Cancer Research in Japan
  10. Project Mirai Cancer Research Grants
  11. Ichiro Kanehara Foundation
  12. Princess Takamatsu Cancer Research Fund
  13. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  14. Suhara Memorial Foundation
  15. Tokyo Biochemical Research Foundation
  16. Japan Foundation for Applied Enzymology
  17. Takeda Science Foundation
  18. Suzuken Memorial Foundation
  19. Akiyama Life Science Foundation
  20. All Japan Coffee Association
  21. Pharmacological Research Foundation, Tokyo
  22. Grants-in-Aid for Scientific Research [19K22478, 19H05412, 20K07558, 20H03524] Funding Source: KAKEN

向作者/读者索取更多资源

The fruit fly Drosophila has played a crucial role in advancing cancer research by providing insights into fundamental mechanisms of cancer development, such as loss of cell polarity. In recent years, scalable Drosophila platforms have proved useful in developing effective anti-cancer regimens for both mammalian models and patients.
Cancer burden has been increasing worldwide, making cancer the second leading cause of death in the world. Over the past decades, various experimental models have provided important insights into the nature of cancer. Among them, the fruit fly Drosophila as a whole-animal toolkit has made a decisive contribution to our understanding of fundamental mechanisms of cancer development including loss of cell polarity. In recent years, scalable Drosophila platforms have proven useful also in developing anti-cancer regimens that are effective not only in mammalian models but also in patients. Here, we review studies using Drosophila as a tool to advance cancer study by complementing other traditional research systems.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据